India to Lebanon: Adalimumab Export Trade Route
India has recorded 1 verified shipments of Adalimumab exported to Lebanon, representing a combined trade value of $59.7K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $59.7K USD. The leading Indian exporter is RELIANCE LIFE SCIENCES PRIVATE LIMITED, which accounts for 100% of total export value with 1 shipments worth $59.7K USD. On the buying side, LEVANT PULSE is the largest importer in Lebanon with $59.7K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Lebanon Adalimumab corridor is one of India's established pharmaceutical export routes, with 1 shipments documented worth a combined $59.7K USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's adalimumab manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $59.7K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (68%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during July–September, with an average transit time of 17 days port-to-port. The route has recorded an annual growth rate of 20.1%, placing it at rank #1 among India's top adalimumab export destinations globally.
On the import side, key buyers of Indian adalimumab in Lebanon include LEVANT PULSE. LEVANT PULSE is the single largest importer with 1 shipments valued at $59.7K USD.
